These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36148016)

  • 1. Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma.
    Xu Z; Xiang L; Peng L; Gu H; Wang Y
    Comput Math Methods Med; 2022; 2022():3445230. PubMed ID: 36148016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the immune and prognostic implication of MASP1 in stomach adenocarcinoma.
    Zhang CH; Xu ZQ; Peng LL; Wang JJ; Gu HT
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6725-6741. PubMed ID: 36196721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas.
    Zhang Z; Wang C; Shi W; Wang Z; Fu W
    Sci Rep; 2024 Sep; 14(1):22342. PubMed ID: 39333689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
    PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.
    Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y
    BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 9. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
    Li X; Lei Y
    Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
    Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
    PeerJ; 2024; 12():e16776. PubMed ID: 38274323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a prognostic metabolic signature in stomach adenocarcinoma.
    Gong Y; Wu S; Dong S; Chen S; Cai G; Bao K; Yang H; Jiao Y
    Clin Transl Oncol; 2022 Aug; 24(8):1615-1630. PubMed ID: 35355155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
    Liu Z; Liu H; Wang Y; Li Z
    BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of
    Zhang S; Xiong H; Yang J; Yuan X
    Front Mol Biosci; 2021; 8():792154. PubMed ID: 35155565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
    Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
    Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics.
    He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H
    PeerJ; 2024; 12():e16951. PubMed ID: 38436027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
    Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
    PeerJ; 2023; 11():e14645. PubMed ID: 36919165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
    Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F
    Front Oncol; 2021; 11():633420. PubMed ID: 33747955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the role of RARs in stomach adenocarcinoma: clinical implications and prognostic biomarkers.
    Ren H; Huang L; Zhang H; Huang M; Meng J; Luo D
    Transl Cancer Res; 2024 Aug; 13(8):3974-3995. PubMed ID: 39262490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.